Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that ...

An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...

Oryzon has been invited to participate at the 8th Sachs Annual Neuroscience Innovation Forum, which will be held on January 12 at the Marines’ Memorial Club in San Francisco (USA). The company will ...

Greater transparency, monitoring, and regulatory oversight are needed around these transactions, a researcher says.

A new study found that fewer African and Asian patients had clinically actionable alterations for lung, breast, and colorectal cancer.

A University of Oklahoma professor and his team have discovered a new way to put atoms into drug molecules that could ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...